Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.

Autor: Tursi, Antonio, Mocci, Giammarco, Allegretta, Leonardo, Aragona, Giovanni, Bianco, Maria Antonia, Colucci, Raffaele, Cuomo, Antonio, Valle, Nicola Della, Ferronato, Antonio, Forti, Giacomo, Gaiani, Federica, Giorgetti, GianMarco, Graziani, Maria Giovanna, Lofano, Katia, Lorenzetti, Roberto, Larussa, Tiziana, Penna, Antonio, Pica, Roberta, Pranzo, Giuseppe, Rodino', Stefano
Zdroj: Inflammatory Bowel Diseases; Mar2023, Vol. 29 Issue 3, p376-383, 8p
Databáze: Complementary Index